CoreWeave (NASDAQ: CRWV) shares rise on announcement of $1.5B senior notes offering. Barclays maintains Equal-Weight rating ...

CoreWeave is highly reliant on Microsoft for revenue. Plus, soon insiders will be able to sell shares after the post-IPO ...

Core Scientific, Inc.'s all-stock deal with CoreWeave, Inc. sparks trader concern, causing volatility in CORZ shares. Click for CRWV risks and analysis of the deal.

As artificial intelligence reshapes global computing demand, infrastructure providers like Applied Digital APLD and CoreWeave ...

CoreWeave’s CORZ acquisition shifts focus to AI growth, securing assets, cutting costs, and driving high-margin revenue.

Core Scientific stock drops 25% after CoreWeave all-stock buyout announcement, reflecting investor fears over valuation risks and lack of price protection.

CoreWeave says first-quarter revenue increased 420% year-over-year to $981.63 million. CoreWeave expects capital expenditures to be between $3 and $3.5 billion in the second quarter, and $20 to ...

The stock could also be subject to early volatility: only 8% of fully diluted shares will be available to trade. Ultimately, CoreWeave is a high risk-reward proposition for the long term investor.

CoreWeave Volatility Highlights Risks of AI Infrastructure Boom ... Reflecting the market battle, the stock’s price surged 19% on Wednesday before retreating 6.7% on Thursday.

Is CoreWeave stock still a buy? Even after their eye-popping surge this year, CoreWeave shares still look like a compelling option for growth investors who can stomach volatility.

These 10 Large-Cap Stocks Have Outgained Palantir in 2025. Here's How Wall Street Thinks They'll Do.

CoreWeave’s $9 billion all-stock deal to acquire Core Scientific sent shares lower as analysts raised concerns over profitability and lingering crypto market volatility.